Lipid excipients offer significant in vivo performance benefits for oral drug delivery by improving solubility/bioavailability, enhancing absorption, and mitigating food effect. While lipids have found commercial success in soft gel capsules and liquid-filled hard capsules, there is growing interest in incorporating the benefits of lipid excipients into oral solid dosage forms, such as tablets.

This presentation will highlight emerging research and formulation strategies that expand the use of lipid excipients in oral tablet development. 

Key topics will include:

• • In vivo benefits of lipid excipients for solubility and permeability.
• • Combining lipids with polymers to optimize oral tablet performance.
• • Incorporating lipids into tablets via common processing techniques.
• • Case studies showcasing lipid-enabled tablet formulations. 

Precise storage conditions are critical to maintaining the quality and integrity of pharmaceutical products. Pharma storage must provide secure, cGMP-compliant solutions backed by advanced infrastructure, including redundant power and cooling systems, 24/7 monitoring, and multi-layered access control.

A full spectrum of storage environments—from ambient, refrigerated, and ICH stability to ultra-low and cryogenic—are needed to meet industry and custom requirements. 

In this webinar, experts from Alcami will explore how integrated services such as materials management, logistics, and on-site support can ensure seamless handling from receipt to delivery, preserving product quality and meeting regulatory standards.

Attendees will gain insight on how to safeguard critical materials, mitigate risk, and navigate complex storage requirements with confidence across every stage of the development lifecycle.

This session will explore the critical role of bioavailability in a drug's success and how softgel technology can be a strategic solution for commercial longevity. Dr. Peter Surman, Dr. Brett Wagner, and Chris Cuthbertson will look at how a molecule's market potential is often limited not by its efficacy but by its poor delivery and absorption. They will explain the scientific challenges of bioavailability, such as poor solubility and stability, and how these issues can lead to increased R&D costs, clinical trial failures, and lost market share.

Using case studies they will demonstrate how strategic formulation can overcome significant challenges, such as a drug's food effect or very low bioavailability. Finally, they will share how early-stage molecule characterization and a partnership with a company like Douglas can be crucial for navigating the complex pathway from candidate selection to market, ultimately helping clients accelerate their drug's journey to patients and achieve market leadership.